Press Release
The shareholders in
Right to participate in the Meeting, etc.
Shareholders who wish to participate in the Meeting shall
be recorded in the share register kept by
Euroclear Sweden AB no later than Thursday,16 November 2023 , andnotify the Company their intention to participate no later than Monday,
20 November 2023 by post toScandinavian Real Heart AB , Kopparbergsvägen 6, 722 13 Västerås, by phone +46 (0)70-643 88 61 or by e-mail jonas.bark@realheart.se. The notification shall state full name, personal identification number/company registration number, shareholding, address, daytime telephone number and, if applicable, information about proxies or assistants (maximum two).
To be entitled to participate in the Meeting, shareholders whose shares are held in the name of a nominee must, in addition to providing notification of their participation in the Meeting, re-register the shares in their own name so that the shareholders are registered in the share register on the record date on Thursday,
Proxies etc.
If a Shareholders shall be represented by proxy, the proxy shall bring a written, dated and by the shareholder signed, power of attorney to the Meeting. The power of attorney may not be older than one year unless indicated that it is valid for a longer period, not exceeding five years. If the proxy is issued by a legal person, the proxy shall bring a current copy of the registration certificate and similar papers of authorisation. In order to facilitate entry to the Meeting, a copy of the power of attorney and other authorisation documents should be attached to the notification to the Meeting. Proxy forms will be available on the Company's website www.realheart.se and will be sent by post to shareholders who contact the Company and state their address.
Processing of personal data
For information on how personal data is processed in connection with the Meeting, please refer to the privacy policy available on
Proposal for agenda
Election of Chairman of the Meeting
Election of one or two persons to verify the minutes
Preparation and approval of the voting list
Approval of the agenda
Determination as to whether the meeting has been duly convened
Determination of number of Board members
Election of Board members
Determination of fees for Board members
Closing of meeting
The Nomination Committee's proposals
Item 1 - Election of Chairman of the Meeting
The Nomination Committee consists, until the Annual General Meeting 2024, of Kim Norström and
Item 6 - Determination of number of Board members
The Nomination Committee proposes that the Board of Directors should consist of eight
ordinary Board members without deputies.
Item 7 -Election of Board members
The Nomination Committee proposes, for the period until the end of the next Annual General Meeting, that the current Board of Directors be supplemented with the following new members: Magnus Öhman,
Magnus Öhman
Born: 1961
Education: MSc in Mechanical Engineering
Experience: Magnus has over 30 years of experience from medtech including R&D leadership in both site and global responsibilities and as Managing Director for the St Jude Medical CRM subsidiary with R&D, manufacturing and distribution operations with over 600 employees and a revenue of
Born: 1952
Education: Pharmacology -
Experience: Stuart has held senior positions in global medical device companies for more than 25 years, guiding companies from research to product commercialisation. Stuart has worked with several heart pump companies, most recently as CEO of
Born: 1987
Education: Bachelor of Science (BSc) in Finance, a Master of Science (MSc) in Regulatory Affairs in Medical Devices, a Harvard University Certificate in Advanced Negotiation Strategy and a Universita Bocconi Certificate in
Experience Giovanni has worked with over 500 startups worldwide and is currently member of several boards. He also organizes the conference
Item 8 - Determination of fees for Board members
The Nomination Committee proposes that board fees for each of the new members according to item 7 above shall be paid with
Information on the number of shares and votes
At the time of issue of this notice, the total number of shares and votes in the Company amounts to 96,994,446.
Shareholders' right to request information
The shareholders are reminded of their right, in accordance with Chapter 7 Section 32 of the Swedish Companies Act (2005:551), to request information from the Board Directors and the CEO at the Meeting.
Provision of documents
Proxy forms as well as other documents required by the Companies Act will be kept available to the shareholders at the Company's head office; Kopparbergsvägen 6, 722 13 Västerås and on the Company's website www.realheart.se.
Copies of the documents will also be sent to shareholders who so request and who provide their postal address.
Västerås in
THE BOARD OF DIRECTORS
For more information please contact:
Phone: +46(0)70 406 49 21
E-mail: inalaura.perkins@realheart.se
Certified Adviser:
https://news.cision.com/real-heart/r/notice-to-attend-the-extraordinary-general-meeting-in-scandinavian-real-heart-ab,c3871675
https://mb.cision.com/Main/12118/3871675/2416052.pdf
(c) 2023 Cision. All rights reserved., source